drugset / Trial / NCT02170740
Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagulation parameters in healthy volunteer subjects.
Timeline
- Start
- 1999-11
- Primary completion
- 2000-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 50 mg | Oral |
| Subject | Dabigatran etexilate | Unknown | 200 mg | Oral |
| Subject | Pantoprazole | Other / unclassified | — | — |
Indications
No indication recorded.